Donna Grogan

Director/Board Member at C4 THERAPEUTICS, INC.

Net worth: 327 108 $ as of 31/05/2026

69 year

Health Technology

Consumer Services

Profile

Donna Roy Grogan is currently Independent Director at C4 Therapeutics, Inc. since 2022 and President at Clementia Pharmaceuticals USA, Inc. since 2014.
Former roles include Independent Director at Momenta Pharmaceuticals, Inc. from 2019 to 2020; Medical Director at Astra Pharmaceuticals, Inc.; Senior Vice President-Clinical Research at Sumitomo Pharma America, Inc. from 2000 to 2007; Chief Medical Officer at DecImmune Therapeutics, Inc., Apofore Corp., Anexon, Inc.; Chief Medical Officer at Clementia Pharmaceuticals, Inc. from 2013 to 2019; and Chief Medical Officer at FoldRx Pharmaceuticals LLC from 2007 to 2010.
Education includes undergraduate studies at College of the Holy Cross (Massachusetts) and a doctorate from the University of Illinois College of Medicine.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
C4 THERAPEUTICS, INC. 0.07%	01/07/2026	74,853 ( 0.07% )	327 108 $	31/05/2026

Donna Grogan active positions

Companies	Position	Start
C4 THERAPEUTICS, INC.	Director/Board Member	29/07/2022
Clementia Pharmaceuticals USA, Inc. Clementia Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	President	01/06/2014

All active positions of Donna Grogan

Former positions of Donna Grogan

Companies	Position	End
MOMENTA PHARMACEUTICALS, INC.	Director/Board Member	01/10/2020
CLEMENTIA PHARMACEUTICALS INC	Chief Tech/Sci/R&D Officer	01/04/2019
FoldRx Pharmaceuticals LLC FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug discovery and clinical development services	Chief Tech/Sci/R&D Officer	01/08/2011
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases	Corporate Officer/Principal	01/01/2007
DecImmune Therapeutics, Inc. DecImmune Therapeutics, Inc. BiotechnologyHealth Technology Develops novel peptides and antibodies for acute and tissue damaging inflammation	Chief Tech/Sci/R&D Officer	-

See the detail of Donna Grogan's experience

Training of Donna Grogan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Donna Grogan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	12
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases	Health Technology
Momenta Pharmaceuticals, Inc. Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases	Health Technology
FoldRx Pharmaceuticals LLC FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug discovery and clinical development services	Health Technology
DecImmune Therapeutics, Inc. DecImmune Therapeutics, Inc. BiotechnologyHealth Technology Develops novel peptides and antibodies for acute and tissue damaging inflammation	Health Technology
Apofore Corp. Apofore Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for diabetes	Health Technology
College of the Holy Cross (Massachusetts) College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Astra Pharmaceuticals, Inc.
Anexon, Inc. Anexon, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cardiovascular diseases	Health Technology
University of Illinois College of Medicine University of Illinois College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Clementia Pharmaceuticals, Inc. Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops treatments for patients suffering from bone disorders and other diseases	Health Technology
C4 Therapeutics, Inc. C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer	Health Technology
Clementia Pharmaceuticals USA, Inc. Clementia Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Health Technology